Dataset from A Randomized, Double-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect

The primary objective of this study is to evaluate the safety and tolerability of single
doses of BIIB061 administered to healthy adult volunteers. Secondary objectives in this study
population are to determine the single-dose pharmacokinetic (PK) profile and the absolute
bioavailability (Fabs) of BIIB061 and to determine the effects of food intake (high-fat,
high-calorie meal) on BIIB061 PK and safety.